ESPID Education. Gonzalez-Granado L. 06/10/09; 3700 Disclosure(s): Nothing to disclose
Luis Gonzalez-Granado
Luis Gonzalez-Granado

This content is available to ESPID members only

Click here for more information or if you are considering becoming an ESPID member.

Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
Learn to differentiate between Multidrug and Extensively drug resistant tuberculosis. Management of both situations.
We report a case of MDR-tuberculosis. Follow up and treatment is discussed.
We report a case of MDR-tuberculosis. Follow up and treatment is discussed.
1.- Sneag DB, Schaaf HS, Cotton MF, Zar HJ.Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J. 2007;26(12):1142-6
2.- Feja K, McNelley E, Tran CS, Burzynski J, Saiman L. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.Pediatr Infect Dis J. 2008;27(10):907-12
3.- Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP. Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA. 2008;300(18):2153-60.
4.- Padayatchi N, Bamber S, Dawood H, Bobat R. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J. 2006;25(2):147-50
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies